What is the socioeconomic impact of coccidioidomycosis in the US?

Updated: Aug 27, 2019
  • Author: Duane R Hospenthal, MD, PhD, FACP, FIDSA, FASTMH; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Coccidioidal disease has a significant socioeconomic impact in the United States. An otherwise healthy individual diagnosed with symptomatic coccidioidomycosis may miss more than one month of school or work. Recent estimates of antifungal medication costs range from $5000 to $20,000 per person per year of therapy for the disease. [3, 21]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!